Format

Send to

Choose Destination
See comment in PubMed Commons below
Neurology. 2001 Jul 24;57(2):321-4.

Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies.

Author information

1
Israeli Teratogen Information Service, Laboratory of Teratology, Jerusalem, Israel.

Abstract

The Israeli Teratogen Information Service prospectively followed up 210 pregnancies with first trimester carbamazepine exposure. Pregnancy outcome was compared with that of two overlapping controls, matched and general (n = 629), exposed to nonteratogenic agents. Our study suggests a twofold increase in the rate of major congenital anomalies (12/160 [carbamazepine] versus 18/560 [general control]; relative risk 2.24; 95% CI 1.1-4.56) and a birth weight reduction of approximately 250 g after in utero exposure to carbamazepine.

PMID:
11468320
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center